Fact CheckerSign in

NCT06871267Recruiting

Dietary Modification In Inflammatory Bowel Disease Patients

Dietary Modification In Patients With Inflammatory Bowel Diseases And Its Impact In Gut Microbiome

Source: ClinicalTrials.gov · Last updated 31 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This research project aimed to develop a culturally appropriate Asian Inflammatory Bowel Disease Diet for the Malaysian population, based on the Crohn's disease exclusion diet (CDED). The study will be conducted in inflammatory bowel disease patients in University Malaya Medical Centre, which are ulcerative colitis and Crohn's disease patients. The objectives of this study are to assess the impact of diet in clinical outcome and gut microbiota changes in patients with inflammatory bowel disease (IBD). The study duration spans 24 weeks, during which comprehensive follow-ups will be conducted at 0, 6, 12, and 24 weeks, respectively. At each follow-up session, participants will be requested to provide stool and blood samples for meticulous assessment of clinical and biochemical responses.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
74 (estimated)
First submitted
24 Feb 2025
Start date
1 Mar 2025
Primary completion date
10 Sept 2025
Lead sponsor
University of Malaya
NCT number
NCT06871267

What you commit to

  • Study type: Interventional
  • Planned participants: 74
  • From 1 Mar 2025 to the primary completion date, 10 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Surgery within 6 months prior to randomization.

Other

  • Presence of stoma.
  • Patient on exclusive enteral nutrition (EEN).

Who the study is looking for

  • Confirmed diagnosis of Crohn's disease according to established clinical, endoscopic, and histological criteria.
  • Mild to moderate diseases (150 to 220 points).
  • Written informed consent obtained.

Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universiti Malaya Medical Centre
Coordinator of this site? Confirm its status
Kuala LumpurMalaysiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.